Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHRONSEAL in Venous Leg Ulcers
NCT00797706Phase 2Unknown
- Sponsor
- Kringle Pharma, Inc.
- Start
- Nov 2008
- Primary completion
- Mar 2010
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
- Countries
- 2
01
Overview
A Phase 2 trial of hepatocyte growth factor in venous leg ulcer (VLU), sponsored by Kringle Pharma, Inc.. Status: unknown.
02
Drugs
hepatocyte growth factor
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT00797706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797706.